Oral self emulsifying powder of lercanidipine hydrochloride: Formulation and evaluation

Powder Technology

Volumn 221, Issue , 2012, Pages 375-382

  Kallakunta, Venkata Raman ^a   Bandari, Suresh ^a   Jukanti, Raju ^a   Veerareddy, Prabhakar Reddy ^a  

^a ST PETER'S INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Dissolution efficiency; Neusilin; Self emulsifying powder; Solubility; Ternary phase diagram

Indexed keywords

CLOUD POINTS; CO-SURFACTANTS; CRYSTALLINE STRUCTURE; DRUG RELEASE; EFFECT OF PH; FREE FLOWING; GLOBULE SIZE; NEUSILIN; OPTIMIZED SYSTEM; PEG-400; TERNARY PHASE DIAGRAMS;

DIAGNOSIS; DISSOLUTION; LIQUIDS; PH EFFECTS; PHASE DIAGRAMS; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; SURFACE ACTIVE AGENTS; X RAY DIFFRACTION;

EMULSIFICATION;

ATTAPULGITE; LERCANIDIPINE; MACROGOL 400; OCTANOIN; POLYSORBATE 80; SURFACTANT;

ADSORPTION; ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DILUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG STRUCTURE; EMULSION; MORPHOLOGY; PH; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TEMPERATURE; THERMODYNAMICS; X RAY DIFFRACTION;

EID: 84858615116     PISSN: 00325910     EISSN: 1873328X     Source Type: Journal    
DOI: 10.1016/j.powtec.2012.01.032     Document Type: Article

References (30)

1. Lipinski C. Poor aqueous solubility-an industry wide problem in drug discovery. American Pharmaceutical Review 2002, 5:82-85.
2. Palmer A.M. New horizons in drug metabolism, pharmacokinetics and drug discovery. Drug News & Perspectives 2003, 16:57-62.
3. Weuts I., Kempen D., Decorte A., Verreck G., Peeters J., Brewster M., Van den Mooter G. Phase behaviour analysis of solid dispersions of loperamide and two structurally related compounds with the polymers PVP-K30 and PVP-VA64. European Journal of Pharmaceutical Sciences 2004, 22:375-385.
4. Ammar H.O., Salama H.A., Ghorab M., Mahmoud A.A. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy. International Journal of Pharmaceutics 2006, 320:53-57.
5. Odeberg J.M., Kaufmann P., Kroon K.G., Hoglund P. Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine. European Journal of Pharmaceutical Sciences 2003, 20:375-382.
6. Balakrishnanan P., Lee B.J., Oh D.H., Kim J.O., Lee Y.I., Kim D.D., Jee J.P., Lee Y.B., Woo J.S., Yong C.S., Choi H.G. Enhanced oral bioavailability of coenzyme Q10 by self-emulsifying drug delivery systems. International Journal of Pharmaceutics 2009, 374:66-72.
7. Pouton C.W. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. European Journal of Pharmaceutical Sciences 2000, 11:S93-S98.
8. Pouton C.W. Self emulsifying drug delivery systems: assessment of the efficiency of emulsification. International Journal of Pharmaceutics 1985, 27:335-348.
9. Prajapati B.G., Patel M. Conventional and alternative methods to improve oral bioavailability of lipophilic drugs. Asian Journal of Pharmaceutical 2007, 1:1-8.
10. Barchielli M., Dolfini E., Farina P., Leoni B., Targa G., Vinnacia V., Tajana A. Clinical pharmacokinetics of lercanidipine. Journal of Cardiovascular Pharmacology 1997, 29:S1-S15.
11. Kommuru T.R., Gurley B., Khan M.A., Reddy I.K. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. International Journal of Pharmaceutics 2001, 212:233-246.
12. Bachynsky M.O., Shah N.H., Patel C.I., Malick A.W. Factors affecting the efficiency of self-emulsifying oral delivery system. Drug Development and Industrial Pharmacy 1997, 23:809-816.
13. Elnaggar Y.S.R., El-Massik M.A., Abdallah O.Y. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. International Journal of Pharmaceutics 2009, 380:133-141.
14. Shafiq S., Shakeel F., Talegaonkar S., Ahmad F.J., Khar R.K., Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation. European Journal of Pharmaceutics and Biopharmaceutics 2007, 66:227-243.
15. Zhang P., Liu Y., Feng N., Xu J. Preparation and evaluation of self micro emulsifying drug delivery system of oridonin. International Journal of Pharmaceutics 2008, 355:269-276.
16. Kang B.K., Lee J.S., Chon S.K., Jeong S.Y., Yuk S.H., Khang G., Lee H.B., Cho S.H. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. International Journal of Pharmaceutics 2004, 274:65-73.
17. Dixit R.P., Nagarsenker M.S. Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. European Journal of Pharmaceutical Sciences 2008, 35:183-192.
18. Carr R.L. Evaluating flow properties of solids. Chemical Engineer 1965, 18:163-168.
19. Quan D.Q., Xu G.X., Wu X.G. Studies on preparation and absolute bioavailability of a self-emulsifying system containing puerarin. Chemical and Pharmaceutical Bulletin 2007, 55:800-803.
20. Balakrishnan P., Lee B.J., Oh D.H., Kim J.O., Hong M.J., Jee J.P., Kim J.A., Yoo B.K., Woo J.S., Yong C.S., Choi H.G. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery systems (SEDDS). European Journal of Pharmaceutics and Biopharmaceutics 2009, 72:539-545.
21. Chambin O., Jannin V., Champion D., Chevalier C., Rochat-Gonthier M.H., Pourcelot Y. Influence of cryogenic grinding on properties of a self-emulsifying formulation. International Journal of Pharmaceutics 2004, 278:79-89.
22. Prasad R.Y.V., Puthli S.P., Eaimtrakarn S., Ishida M., Yoshikawa Y., Shibata N., Takada K. Enhanced intestinal absorption of vancomycin with labrasol and D-α-tocopheryl PEG 1000 succinate in rats. International Journal of Pharmaceutics 2003, 250:181-190.
23. J.E. Lacy, J.K. Embleton, Delivery systems for hydrophobic drugs. US Patent, 5645856 (1997).
24. Patel A.R., Vavia P.R. Preparation and in vivo evaluation of SMEDDS (self microemulsifying drug delivery system) containing fenofibrate. The AAPS Journal 2007, 9:E344-E352.
25. Craig D.Q.M., Barker S.A., Banning D., Booth S.W. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. International Journal of Pharmaceutics 1995, 114:103-110.
26. Pouton C.W. Formulation of self-emulsifying drug delivery systems. Advanced Drug Delivery Reviews 1997, 25:47-58.
27. Constanitinides P.P., Scalart J.P., Lancaster C., Marcello J., Marks G., Ellens H. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsion incorporating medium-chain glycerides. Pharmaceutical Research 1994, 11:1385-1390.
28. Wu W., Wang Y., Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. European Journal of Pharmaceutics and Biopharmaceutics 2006, 63:288-294.
29. Pouton C.W., Porter C.J.H. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Advanced Drug Delivery Reviews 2008, 60:625-637.
30. Hancock B.C., Zographi G. Characteristics and significance of the amorphous state in pharmaceutical systems. Journal of Pharmaceutical Sciences 1997, 86:1-12.